The healthcare industry remains stressed despite a marked improvement in the pandemic situation, with patient visits increasing steadily and elective procedures resuming.
Abbott Laboratories
-(ABT)
XNYS:ABT
Abbott Laboratories (ABT) Q2 2021 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q2 2021 earnings call dated Jul. 22, 2021 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing and
Abbott Laboratories ease past street targets: Infographic
Abbott Laboratories (NYSE: ABT) reported second-quarter 2021 financial results before the regular market hours on Thursday. The pharmaceutical giant reported Q2 sales
Earnings calendar for the week of July 19
Despite strong trading and encouraging news from the labor market, benchmark stock indexes pulled back after making modest gains early in the
Abbott Laboratories (ABT) Q1 2021 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Scott Michael Leinenweber -- Vice President of Investor Relations, Licensing
Abbott Laboratories (ABT) Earnings: 1Q21 Key Numbers
Abbott Laboratories (NYSE: ABT) reported first quarter 2021 earnings results today. Sales increased 35.3% year-over-year to $10.5 billion. On an organic basis,
Earnings calendar for the week of April 19
The market rally gathered pace this week amid impressive quarterly results, led by the banking sector, and positive economic data. Leading stock
Abbott’s (ABT) stock can give high returns, thanks to COVID-related tailwinds
The financial performance of Abbott Laboratories (NYSE: ABT) has been positively impacted by the high demand for COVID-related diagnostic services. However, in
Abbott Laboratories (ABT) Q4 2020 Earnings Call
Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions Robert
Abbott Laboratories (ABT) Q4 2020 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions
ABT Earnings: Key numbers from Abbott Laboratories Q4 financial results
Abbott (NYSE: ABT) today announced its fourth-quarter financial results for the period ended December 31, 2020. Net earnings for the fourth quarter
Earnings calendar for the week of January 25
Leading stock indices continued the recent rally this week, with S&P 500 and Dow Jones Industrial Average setting new records helped mainly
Abbott Laboratories (ABT) Q3 2020 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing and
ABT Earnings: Key numbers from Abbott Laboratories Q3 financial results
Abbott (NYSE: ABT) today announced its third quarter financial results for the period ended September 30, 2020. Net earnings for the third
Earnings calendar for the week of Oct. 19
Undoubtedly the biggest event of the week was the launch of iPhone 12, the latest in Apple's smartphone series. Pre-orders for the
Abbott (ABT) could make a new 52-week high after upbeat Q2 results and rosier outlook
Thanks to the COVID-19 testing growth, after reporting solid second quarter results and strong outlook for fiscal 2020 last Thursday, shares of
Abbott Laboratories (ABT) Q2 2020 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q2 2020 earnings call dated July 16, 2020 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing and Acquisitions
Infographic: Abbott (ABT) reports Q2 2020 earnings
Abbott Laboratories (NYSE: ABT) reported second-quarter financial results before the regular trading hours on Thursday. Revenue for the quarter fell 8% to
Johnson & Johnson mentioned COVID 80 times during earnings call, vs. Abbott’s 16
Global pharma giants Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE: JNJ) announced their earnings for Q1 2020 last week. Despite
Abbott Laboratories (NYSE: ABT) Q1 2020 Earnings Call Transcript
Abbott Laboratories (ABT) Q1 2020 earnings call dated Apr. 16, 2020 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing and Acquisitions
A graphical representation of Abbott Laboratories (ABT) Q1 2020 earnings results
Abbott Laboratories (NYSE: ABT) reported its financial results for the quarter ended March 31, 2020 today. The company reported a 16% drop